NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Amyloid Solution Inc.

Amyloid Solution Inc.

Private
South KoreaHealthcare & Life Scienceshttps://amyloidsolution.com/

Last Round

Series C

May 18, 2022

Est. Valuation

$193.7M

Total Funding Raised

$66.6M

Company Overview

Amyloid Solution Inc. is a biotechnology company that develops therapeutic drugs for the treatment of Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

Alzheimer's diseasebiotechnologydrug discoverysmall moleculeneurodegenerationamyloid-betatau proteinclinical trialsdrug developmenttherapeutic candidatepharma pipelinebiotech startupdrug licensingneuroscience researchpre-clinical research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amyloid Solution Inc. Comparables

Compare Amyloid Solution Inc. with similar companies based on industry and business-model similarity.

Amyloid Solution Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AriBio
88%
Adel, Inc.
81%
Alzheon
79%

Amyloid Solution Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 18, 2022
Series B ExtensionJun 20, 2020
Series BApr 10, 2020
Series AMar 26, 2019
AcceleratorDec 1, 2017

Amyloid Solution Inc. Investors

Notable investors and investment history

Amyloid Solution Inc. investors
InvestorRounds
KB InvestmentSeries B Extension
POSCO CapitalSeries B Extension, Series C
KCLAVIS InvestmentSeries B
Starset InvestmentSeries A
TS InvestmentSeries A, Series B, Series C
Innopolis PartnersSeries A
Wonik Investment PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2022

    $35.5M round with participation from POSCO Capital.

Amyloid Solution Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Amyloid Solution Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Amyloid Solution Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range18
Year Founded2017
Last FundingMay 18, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.